Vivos Therapeutics Inc (VVOS) stock news · rev $17.4M
Vivos Therapeutics Inc (VVOS) is a medical devices company listed on NASDAQ.
This VVOS news page leads with what Vivos Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for VVOS yet. We will not pad this page with generic market recap.
Latest reported VVOS revenue for 2025-12-31 was $17.4M. Net income was -$21.2M. Revenue was up 16.0% from 2024-12-31 to 2025-12-31. VVOS currently screens at market cap $7.1M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the VVOS stock page; for the tape open the quote page.
VVOS stock news FAQ
What are VVOS's latest revenue and net income?
Latest cached Vivos Therapeutics Inc (VVOS) revenue for Dec 31, 2025 was $17.4M. Net income was -$21.2M. Statements: https://lician.com/financials/vvos
How did VVOS revenue change from the prior cached period?
Cached Vivos Therapeutics Inc (VVOS) revenue was up 16.0% from $15.0M (Dec 31, 2024) to $17.4M (Dec 31, 2025). Statements: https://lician.com/financials/vvos
What is VVOS's market cap?
Vivos Therapeutics Inc (VVOS) market cap is $7.1M on the latest cached fundamentals snapshot.
What kind of company is VVOS?
Vivos Therapeutics Inc (VVOS) is a medical devices company listed on NASDAQ.
Where is VVOS stock news listed?
Cached stock news for Vivos Therapeutics Inc (VVOS) is listed at https://lician.com/news/vvos. Filings: https://lician.com/sec/vvos
Not investment advice.